Authors: | Weiss, J. M.; Gupta, S.; Burke, C. A.; Axell, L.; Chen, L. M.; Chung, D. C.; Clayback, K. M.; Dallas, S.; Felder, S.; Gbolahan, O.; Giardiello, F. M.; Grady, W.; Hall, M. J.; Hampel, H.; Hodan, R.; Idos, G.; Kanth, P.; Katona, B.; Lamps, L.; Llor, X.; Lynch, P. M.; Markowitz, A. J.; Pirzadeh-Miller, S.; Samadder, N. J.; Shibata, D.; Swanson, B. J.; Szymaniak, B. M.; Wiesner, G. L.; Wolf, A.; Yurgelun, M. B.; Zakhour, M.; Darlow, S. D.; Dwyer, M. A.; Campbell, M. |
Title: | NCCN Guidelines® Insights: Genetic/familial high-risk assessment: Colorectal, version 1.2021: Featured updates to the NCCN Guidelines |
Abstract: | Identifying individuals with hereditary syndromes allows for timely cancer surveillance, opportunities for risk reduction, and syndrome-specific management. Establishing criteria for hereditary cancer risk assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provides recommendations for the assessment and management of patients at risk for or diagnosed with high-risk colorectal cancer syndromes. The NCCN Genetic/Familial High-Risk Assessment: Colorectal panel meets annually to evaluate and update their recommendations based on their clinical expertise and new scientific data. These NCCN Guidelines Insights focus on familial adenomatous polyposis (FAP)/attenuated familial adenomatous polyposis (AFAP) syndrome and considerations for management of duodenal neoplasia. © JNCCN |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 19 |
Issue: | 10 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2021-10-15 |
Start Page: | 1122 |
End Page: | 1132 |
Language: | English |
DOI: | 10.1164/jnccn.2021.0048 |
PROVIDER: | scopus |
PUBMED: | 34666312 |
DOI/URL: | |
Notes: | Article -- Export Date: 1 December 2021 -- Source: Scopus |